All these findings demonstrate that CELSR3, GPSM2, and CHEK1 were upregulated in hepatocellular carcinoma and linked to prognosis of patients with hepatocellular carcinoma. The gene discussed is CHEK1; the disease is hepatocellular carcinoma.